ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 24 filers reported holding ENVVENO MEDICAL CORPORATION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,177 | +73.8% | 11,350 | -0.6% | 0.00% | – |
| Q2 2023 | $35,206 | -34.1% | 11,415 | 0.0% | 0.00% | – |
| Q1 2023 | $53,452 | -7.8% | 11,415 | 0.0% | 0.00% | – |
| Q4 2022 | $58,000 | -19.4% | 11,415 | 0.0% | 0.00% | – |
| Q3 2022 | $72,000 | +63.6% | 11,415 | -1.6% | 0.00% | – |
| Q2 2022 | $44,000 | +780.0% | 11,595 | +1358.5% | 0.00% | – |
| Q1 2022 | $5,000 | -80.0% | 795 | -79.3% | 0.00% | – |
| Q4 2021 | $25,000 | – | 3,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 401,200 | $2,556,000 | 2.70% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,396,000 | 0.14% |
| Perceptive Advisors | 781,615 | $4,978,000 | 0.10% |
| Kepos Capital LP | 50,000 | $319,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 15,000 | $96,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 33,372 | $213,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 49,600 | $316,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,045 | $13,000 | 0.00% |
| NORTHERN TRUST CORP | 13,906 | $89,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |